The DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Open accessAbstract
Multiple lines of evidence suggest that CD4+ lymphocytes initiate autoimmune responses against myelin antigens in multiple sclerosis (MS). The increased frequency of activated myelin-specific cells in MS patients indicates that the activation of autoreactive cells represents a central event in the pathogenesis of the disease. We identified a CD4+ subpopulation that is characterized phenotypically by the persistent absence of surface CD28 expression and functionally by CD28-independent activation and Th1 cytokine secretion. Owing to their costimulation-independent activation and their expression of a full agonist signaling activation pattern, CD4+CD28- cells have the potential to initiate autoimmune responses in the central nervous system, a compartment devoid of professional antigen presenting cells. Long-term memory CD4+CD28- cells produce high amounts of IFN-gamma and maximally upregulate IFN-gamma and IL-12Rbeta2 chain expression in the absence of costimulation. They exhibit prominent growth characteristics and increased survival after activation, likely related to their persistent lack of CTLA-4 surface expression. The CD4+CD28- population is expanded in a subgroup of MS patients. Myelin basic protein-specific cells detected in this cell subset may play an important role in the inflammatory response within the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Schmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Schirmer, M., Vallejo, A. N., Weyand, C. M., & Goronzy, J. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.1018 · Cited by 191
Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways
Vallejo, A. N., Schirmer, M., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6301 · Cited by 169
Research works printed but not linked: 38
- 10.1038/80516 · DOI · Paper page
- 10.1146/annurev.iy.10.040192.001101 · DOI · Paper page
- 10.1038/346183a0 · DOI · Paper page
- 10.1084/jem.179.3.973 · DOI · Paper page
- 10.1126/science.1689076 · DOI · Paper page
- Sharief, 1993, J Neurol Neurosurg Psychiatry, 56, 169, 10.1136/jnnp.56.2.169 · DOI
- 10.1002/1531-8249(200002)47:2<269::AID-ANA23>3.0.CO;2-G · doi:10.1002/1531-8249(200002)47:2<269::aid-ana23>3.0.co;2-g
- 10.1002/ana.410340210 · DOI
- Lejon, 1999, J Immunol, 163, 5708, 10.4049/jimmunol.163.10.5708 · DOI
- 10.1016/S0967-5868(95)80007-7 · doi:10.1016/s0967-5868(95)80007-7
- 10.1038/72323 · DOI
- 10.1084/jem.187.3.427 · DOI · Paper page
- 10.1084/jem.184.2.783 · DOI · Paper page
- 10.1016/S0952-7915(99)00036-9 · doi:10.1016/s0952-7915(99)00036-9
- 10.1016/1074-7613(95)90000-4 · DOI · Paper page
- 10.1016/S1074-7613(00)80480-X · DOI · Paper page
- 10.1016/S1074-7613(00)80091-6 · DOI · Paper page
- 10.1084/jem.192.12.1719 · doi:10.1084/jem.192.12.1719
- 10.1016/S0167-5699(98)01299-7 · DOI · Paper page
- Scholz, 1998, J Immunol, 160, 1532, 10.4049/jimmunol.160.3.1532 · DOI · Paper page
- 10.1172/JCI1528 · DOI · Paper page
- Chapman, 1996, J Immunol, 157, 4771, 10.4049/jimmunol.157.11.4771 · DOI
- Muraro, 2000, J Immunol, 164, 5474, 10.4049/jimmunol.164.10.5474 · DOI
- Zheng, 1998, J Immunol, 160, 763, 10.4049/jimmunol.160.2.763 · DOI
- 10.1016/S0952-7915(97)80084-2 · DOI
- 10.1016/0092-8674(93)90074-Z · DOI · Paper page
- Probert, 1996, J Immunol, 157, 3183, 10.4049/jimmunol.157.7.3183 · DOI
- 10.1046/j.1365-2249.1998.00695.x · DOI
- 10.1074/jbc.273.14.8119 · DOI · Paper page
- 10.1084/jem.189.10.1521 · DOI
- 10.1038/35003228 · DOI · Paper page
- 10.1038/35003235 · DOI · Paper page
- 10.1016/S1074-7613(00)80195-8 · DOI · Paper page
- 10.1084/jem.189.6.969 · DOI
- 10.1172/JCI5857 · DOI · Paper page
- Perrin, 1999, J Immunol, 163, 1704, 10.4049/jimmunol.163.3.1704 · DOI
- Perrin, 1996, J Immunol, 157, 1333, 10.4049/jimmunol.157.4.1333 · DOI · Paper page
- 10.1128/JVI.74.18.8349-8357.2000 · DOI
Cited by
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Self-citationVoltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 799
CD28− T cells: their role in the age-associated decline of immune function
Weng, N.-P., Akbar, A. N., & Goronzy, J. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.013 · Cited by 633
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
Metadata
- Authors
- Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-10-15
- Volume
- 108
- Issue
- 8
- Pages
- 1185-1194
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2056769769
- Cited by
- 243
- References
- 4
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.